Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.40 |
| ▸ | MEN1 | O00255 | 4/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.40 |
| ▸ | BLM | P54132 | 3/20 | 0.40 |
| ▸ | USP2 | O75604 | 3/20 | 0.40 |
| ▸ | RECQL | P46063 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.36 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.36 |
| ▸ | XIAP | P98170 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8663021 | 0.80 | XIAP (0.37) | MAPTMEN1MAPK1KMT2AALDH1A1 | |
| SCHEMBL21463 | 0.80 | MAPT (0.41) | MAPTMEN1MAPK1KMT2AALDH1A1 | |
| SCHEMBL11664836 | 0.73 | — | — | |
| Duroquinone SCHEMBL11408085 | 0.72 | DDAH1 (0.36) | MAPTMEN1MAPK1KMT2AALDH1A1 | |
| SCHEMBL15597606 | 0.69 | XIAP (0.45) | MAPTMEN1MAPK1KMT2AALDH1A1 | |
| SCHEMBL16921972 | 0.69 | MALT1 (0.35) | MAPTMEN1MAPK1KMT2AKDM4E | |
| SCHEMBL13267620 | 0.69 | ALOX5 (0.47) | MAPTMEN1MAPK1KMT2AALDH1A1 | |
| SCHEMBL19604150 | 0.69 | S100A4 (0.39) | MAPTMEN1MAPK1KMT2AKDM4E | |
| SCHEMBL13986038 | 0.69 | CDC25A (0.38) | MAPTMEN1MAPK1KMT2AALDH1A1 | |
| SCHEMBL19413742 | 0.69 | MAPT (0.43) | MAPTMEN1MAPK1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4153553-B1 | PHOTOOXIDATION OF 2,3,5-TRIMETHYLPHENOL | DSM IP ASSETS BV (NL) | 2024-01-31 | — | — | EP | disclosed |
| EP-4153555-B1 | PHOTOOXIDATION OF PHENOLIC COMPOUNDS | DSM IP ASSETS BV (NL) | 2024-01-31 | — | — | EP | disclosed |
| EP-4153554-B1 | PHOTOOXIDATION OF 2,3,6-TRIMETHYLPHENOL | DSM IP ASSETS BV (NL) | 2024-01-31 | — | — | EP | disclosed |
| US-20230035690-A1 | MACHINE LEARNING TOOLS AND A PROCESS TO DISCOVER NEW NATURAL PRODUCTS BY LINKING GENOMES AND METABOLOMES IN FUNGI | NORTHWESTERN UNIVERSITY | 2023-02-02 | — | — | US | disclosed |
| US-20170342094-A1 | HETEROARYL INHIBITORS OF PDE4 | Tetra Discovery Partners, LLC | 2017-11-30 | — | — | US | disclosed |
| US-20170334866-A1 | CYSTATHIONINE-GAMMA-LYASE (CSE) INHIBITORS | SOVA PHARMACEUTICALS, INC. | 2017-11-23 | — | — | US | disclosed |
| US-20170327478-A1 | CYSTATHIONINE-GAMMA-LYASE (CSE) INHIBITORS | SOVA PHARMACEUTICALS, INC. | 2017-11-16 | — | — | US | disclosed |
| US-9777024-B2 | Heteroaryl inhibitors of PDE4 | Tetra Discovery Partners, LLC (US) | 2017-10-03 | — | — | US | disclosed |
| US-9771339-B2 | Cystathionine-γ-lyase (CSE) inhibitors | SOVA PHARMACEUTICALS, INC. (US) | 2017-09-26 | — | — | US | disclosed |
| US-9725426-B2 | Cystathionine-γ-lyase (CSE) inhibitors | SOVA PHARMACEUTICALS, INC. (US) | 2017-08-08 | — | — | US | disclosed |
| US-20150266837-A1 | CYSTATHIONINE-GAMMA-LYASE (CSE) INHIBITORS | SOVA PHARMACEUTICALS, INC. | 2015-09-24 | — | — | US | disclosed |
| WO-2015112902-A2 | CYSTATHIONINE-(gamma)-LYASE (CSE) INHIBITORS FOR TREATING PAIN | SOVA PHARMACEUTICALS, INC. (US) | 2015-07-30 | — | — | WO | disclosed |
| US-20150202186-A1 | CYSTATHIONINE-(gamma)-LYASE (CSE) INHIBITORS FOR TREATING PAIN | SOVA PHARMACEUTICALS, INC. | 2015-07-23 | — | — | US | disclosed |
| US-20150175561-A1 | CYSTATHIONINE-GAMMA-LYASE (CSE) INHIBITORS | SOVA PHARMACEUTICALS, INC. (US) | 2015-06-25 | — | — | US | disclosed |
| US-20150119362-A1 | HETEROARYL INHIBITORS OF PDE4 | Tetra Discovery Partners, LLC | 2015-04-30 | — | — | US | disclosed |
| WO-2014018571-A2 | USE OF CSE INHIBITORS FOR THE TREATMENT OF CUTANEOUS INJURIES OR CONDITIONS AND SLEEP-RELATED BREATHING DISORDERS | SOVA PHARMACEUTICALS, INC. (US) | 2014-01-30 | — | — | WO | disclosed |
| WO-2014018570-A1 | CYSTATHIONINE-Υ-LYASE (CSE) INHIBITORS | SOVA PHARMACEUTICALS, INC. (US) | 2014-01-30 | — | — | WO | disclosed |
| US-7459473-B2 | N-linked sulfonamides of N-heterocyclic carboxylic acids or carboxylic acid isosteres | GLIA MED, INC. (US) | 2008-12-02 | — | — | US | disclosed |
| US-20070110726-A1 | Rust disease control by Aphanocladium album and/or Beauveria brongniartii | PHYTOMYCO RESEARCH CORPORATION (US) | 2007-05-17 | — | — | US | disclosed |
| US-4867751-A | HAIR DYES | L'OREAL (FR) | 1989-09-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150175561-A1 | CYSTATHIONINE-GAMMA-LYASE (CSE) INHIBITORS | CBS, CTH, BHMT | MAPT 2893/4885MEN1 3008/4885MAPK1 3124/4885 |
| US-20170334866-A1 | CYSTATHIONINE-GAMMA-LYASE (CSE) INHIBITORS | CBS, CTH, BHMT | MAPT 2893/4885MEN1 3008/4885MAPK1 3124/4885 |
| US-20170327478-A1 | CYSTATHIONINE-GAMMA-LYASE (CSE) INHIBITORS | CBS, CTH, BHMT | MAPT 2893/4885MEN1 3008/4885MAPK1 3124/4885 |
| US-20070110726-A1 | Rust disease control by Aphanocladium album and/or Beauveria brongniartii | ERG28, HLA-A, GET3 | MAPT 216/4885MEN1 1428/4885MAPK1 3733/4885 |
| US-20150119362-A1 | HETEROARYL INHIBITORS OF PDE4 | PDE4A, PDE4B, PDE4C | MAPT 4329/4885MEN1 3207/4885MAPK1 3462/4885 |
| US-20150266837-A1 | CYSTATHIONINE-GAMMA-LYASE (CSE) INHIBITORS | CBS, CTH, BHMT | MAPT 2893/4885MEN1 3008/4885MAPK1 3124/4885 |
| US-20170342094-A1 | HETEROARYL INHIBITORS OF PDE4 | PDE4A, PDE4B, PDE4C | MAPT 4241/4885MEN1 4531/4885MAPK1 2441/4885 |
| US-20150202186-A1 | CYSTATHIONINE-(gamma)-LYASE (CSE) INHIBITORS FOR TREATING PAIN | CBS, CTH, MTR | MAPT 1719/4885MEN1 4381/4885MAPK1 3542/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.